Biodistribution and Dosimetry Evaluation of [124I]FIAU

Completed · Phase 1

Conditions studied: Prosthesis Related Infections

In brief

This protocol will evaluate the biodistribution and dosimetry of \[124I\]FIAU in both healthy volunteers and patients with prosthetic joint infections. This pilot study will also investigate the safety and tolerability of \[124I\]FIAU.

Key facts

Study ID

NCT01337466

Run by

BioMed Valley Discoveries, Inc

People needed

12

Starts

2010-12-01

Expected to finish

2013-03-01

Last updated by the study team

2013-06-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
• Sinai Hospital of Baltimore — Baltimore, Maryland, United States
• North Shore long Island Jewish Medical Center — Lake Success, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.